IMR
IMRICOR CDI FORUS [IMR]
Healthcare · ASX Small Cap
$1.9850 +2.3%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical61
Catalyst50
Sentiment50
Fundamental55
Momentum58
Risk Gate45
Get alerts when IMR's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Trading above the 200-day average — the long-term trend is on your side
- Strong cash runway (9 quarters)
- Very high P/S ratio (2174.0x)
- Revenue in sharp decline (-83%)
- CANSLIM I: Institutional ownership (18%)
- Sentiment is mixed — no strong consensus either way
- Positive long-term momentum — up 24% over the past year
- The bigger volume days are the up days — volume-weighted momentum is positive (1.97%/day)
- Beneish M-Score -2.07 (grey zone -2.22 to -1.78): possible earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- Piotroski F-Score weak (3/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -83% — the top line is shrinking
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about IMR
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Form 10 Registration with the U.S. SEC
NONE Imricor Releases FY25 Results
NONE Appendix 4E and FY25 Financial Accounts
LOW FY25 Results Investor Presentation
Recent ASX Announcements
| 2026-03-18 | Form 10 Registration with the U.S. SEC PRICE SENSITIVE |
| 2026-02-24 | FY25 Results Investor Presentation PRICE SENSITIVE |
| 2026-02-24 | Imricor Releases FY25 Results PRICE SENSITIVE |
| 2026-02-24 | Appendix 4E and FY25 Financial Accounts PRICE SENSITIVE |
| 2026-02-17 | Na Homolce to Become 3rd Site for VISABL-VT PRICE SENSITIVE |
Key Metrics
$635.5M
Market Cap
378K
Avg Volume
1.3x
Vol Ratio
$1.11 — $2.25
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-1221.3%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 86% |
| L | Leader vs Laggard | pass | RS: 7 |
| I | Institutional Sponsorship | pass | Inst: 18% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #69 of 117 · Sector avg: 46
View all Healthcare signals →Track IMR and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required